Literature DB >> 28220930

Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis.

Rafael Díaz de la Guardia1, Juan Gonzalo Correa2, Belén López-Millán1, Manel Juan3, Clara Bueno1, Francisco Cervantes2, Pablo Menéndez1,4.   

Abstract

Entities:  

Keywords:  MSCs; inflammation; monocytes; myelofibrosis; peripheral blood

Mesh：

Year:  2017        PMID： 28220930     DOI： 10.1111/bjh.14507

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Myelofibrosis osteoclasts are clonal and functionally impaired.

Authors:  Ivo Veletic; Taghi Manshouri; Asha S Multani; C Cameron Yin; Lei Chen; Srdan Verstovsek; Zeev Estrov
Journal:  Blood       Date:  2019-02-11       Impact factor: 22.113

2.  GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes.

Authors:  Taghi Manshouri; Ivo Veletic; Ping Li; C Cameron Yin; Sean M Post; Srdan Verstovsek; Zeev Estrov
Journal:  Cell Death Dis       Date:  2022-05-20       Impact factor: 9.685

3.  IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.

Authors:  Belen Lopez-Millan; Rafael Diaz de la Guardia; Heleia Roca-Ho; Eduardo Anguita; Abul B M M K Islam; Damia Romero-Moya; Cristina Prieto; Francisco Gutierrez-Agüera; Jose Antonio Bejarano-Garcia; Jose Antonio Perez-Simon; Paula Costales; Montse Rovira; Pedro Marín; Silvia Menendez; Mar Iglesias; Jose Luis Fuster; Alvaro Urbano-Ispizua; Fernando Anjos-Afonso; Clara Bueno; Pablo Menendez
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

4.  The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis.

Authors:  Martina Barone; Lucia Catani; Francesca Ricci; Marco Romano; Dorian Forte; Giuseppe Auteri; Daniela Bartoletti; Emanuela Ottaviani; Pier Luigi Tazzari; Nicola Vianelli; Michele Cavo; Francesca Palandri
Journal:  Oncoimmunology       Date:  2020-06-23       Impact factor: 8.110
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.